…that operates in compliance with current good laboratory practices. This group works seamlessly with the manufacturing team to generate clinical-grade T cells in compliance with current good manufacturing practice. Furthermore,…
Glioblastoma (GBM) is the most common malignant brain tumor in adults. It is incurable, with average patient survival of about 13 months even with an aggressive therapeutic regimen consisting of…
…T cells as a complementary immunotherapy to augment traditional treatment strategies. The engineered T cells eradicate large tumors in pre-clinical experiments. In this project, we will conduct FDA-mandated pre-clinical experiments,…
…need to develop new therapies. We propose to develop a therapy, called immunotherapy, which uses the patient’s own immune system to destroy their sarcoma. Immunotherapies comes in many different forms,…
…of time. We will test these T cells in animal models and translate these findings into human T cells as well. The goal is to generate super-soldier type T cells,…
…a novel bispecific molecule that we have designed and constructed in our laboratory, called ‘TanCAR’. We will further test the function of these bispecific T cells against melanoma cells in…
…tumor cells and kill them. In this grant, we will identify the optimal protocol to load various types of cell carriers with viruses and test them in animal models. In…
…ovarian cancer, a disease which kills more than 14,000 women each year, and for which there are no effective treatment options. These CAR T cells can effectively and comprehensibly kill…
…derived from CD34+ HSCs combined with HSC transplantation may provide enhanced anti-B-ALL-specific NK effectors with long-term persistence, thus likely increasing the efficacy of NK cell therapy for B-ALL. To test…
…Kids of Family Centers for 12 years. In 2003, Mrs. Netter was awarded the Louise Grisafi Community Health Award in recognition of her volunteer contributions to the community. In addition…
…through athleticism, community outreach and direct service. To learn more visit swimacrossamerica.org/fairfieldcounty or follow on Facebook, Twitter or Instagram @SAAFairfieldCo or email michele@swimacrossamerica.org or nancycarr@swimacrossamerica.org. Download Press Release as pdf…
…for cancer through athleticism, community outreach and direct service. To learn more visit swimacrossamerica.org/fc or follow on Facebook, Twitter or Instagram @SAAFairfieldCo or email nancycarr@swimacrossamerica.org. Download Press Release as pdf…
…and quicken this communication between dendritic cells and T cells. Doctors add dendritic cells already armed with the download of the cancer cells’ characteristics. Alliance for Cancer Gene Therapy has…
…the ACGT Awards Luncheon, you may still show your support by making a donation to support ACGT’s Research Fellows and Programs. Please download our response form here and return with your payment….
…cell and gene therapies focusing on solid tumors. ACGT’s alliance of researchers, clinicians, companies, and non-profit partners have the opportunity to hear from the trailblazers driving clinical advances. Attendees participate in working…
…research community, Giving Tuesday is integral in helping us take the next steps toward our goal. Donations ensure we can fund the necessary research and studies to prove cell and…
…to treat complex and challenging solid tumors. SIGN UP FOR MORE ADVANCEMENTS Page sources Implant Churns Out CAR-T Cells to Combat Cancer in Animal Models. UNC School of Medicine. Retrieved…
…shaped by laboratory research. When laboratory research data gain traction, results of continued testing may lead to clinical trials – carefully controlled research studies that test the safety and effectiveness…
…brain tumors. They began their careers as neurologists (brain cancer experts), completing clinical residencies in neurology at the Autonomous University of Barcelona in Spain. From 1994-1997, their focus shifted to…
